Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2017.08.15
关于召开2017年第三次暂时股东大会的通知通告
2017.08.15
第四届董事会第四次聚会决议通告
2017.08.09
关于妄想刊行股份购置资产的停牌希望通告
2017.08.09
关于自力财务照料名称变换的通告
2017.08.03
华融证券股份有限公司关于公司果真刊行2016年公司债券重大事项受托治理事务暂时报告
2017.08.02
关于妄想刊行股份购置资产的停牌希望通告
2017.07.29
2017年半年度业绩快报
2017.07.26
关于妄想刊行股份购置资产的停牌希望通告
2017.07.25
自力董事爆发变换的通告
2017.07.22
2017年第二次暂时股东大会的执法意见书
第一页
上一页
69
70
71
72
73
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】